Clinical case of botryomycome fulminant at the center of diagnostic and treatment of tuberculosis of Baleng (West - Cameroon)

Pan Afr Med J. 2013 Apr 4:14:131. doi: 10.11604/pamj.2013.14.131.2387. Print 2013.

Abstract

Botryomycome also called pyogenic granuloma, is an inflammatory tumor of the skin and mucous membranes often caused by superinfection of minor traumatism. Its uniqueness lies in its granulomatous organization in which each granulation contains bacteria and the predominance of many newly formed blood vessels, with the lights on variables ratings and a turgid endothelium responsible for the ulcero-hemorragic appearance. This delicate condition poses a real problem of treatment which included: an appropriate antibiotherapy, surgical removal or electrocoagulation which, until today is more difficult in countries with limited income. An octogenarian came to our hospital with a large mass on the left foot. This mass had the appearance of a malignant tumor. However, the anatomopathologic diagnosis showed that it was a pyogenic granuloma. The importance of the mass, its location on the sole of the foot, imposed the functional impairment of this member. Electrocoagulation is not available in our hospital and the surgical excision proposed was refused by the patient. The patient was treated with the antibiotics Ceftriaxone and Gentalline at indicated doses for 15 days. After the failure of that antibiotherapy treatment, as a last resort, the patient was treated for a month with another combination of antibiotics (free of cost) made of dapsone and rifampicin. This new combination gave very good results. This example shows dapsone and rifampicin can be use as a new weapon for the management of pyogenic granuloma in countries with limited incomes.

Keywords: Botryomycome fulminant; Dapsone; Inflammation; Rifampicin; diagnosis; pyogenic granuloma or botyomycome.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use
  • Cameroon
  • Foot Diseases* / drug therapy
  • Granuloma, Pyogenic* / drug therapy
  • Humans
  • Male

Substances

  • Anti-Bacterial Agents